BT
Venture capital firm profile
Venture capital firm profile
bm|t invests venture and growth capital in innovative companies, primarily in Thuringia, through regional funds supporting company development and expansion.
Primarily Thuringia, Germany
Growth
Direct equity: EUR 100,000–10 million, maximum 49.9% ownership and planned exit after 3–7 years. Silent/mezzanine participation: EUR 100,000–5 million, market interest and up to ten years. Fund-specific limits and co-investment requirements apply; not one universal cheque range. Business-plan review, due diligence and investment-committee approval precede negotiated milestone-based tranches.
Direct equity: EUR 100,000–10 million, maximum 49.9% ownership and planned exit after 3–7 years. Silent/mezzanine participation: EUR 100,000–5 million, market interest and up to ten years. Fund-specific limits and co-investment requirements apply; not one universal cheque range. Business-plan review, due diligence and investment-committee approval precede negotiated milestone-based tranches.
Sources checked
bm|t is Thuringia’s investment company, providing venture capital and private equity to innovative, growth-oriented businesses. It confirmed leading Active Medical Xcellence’s financing through WBF II on 9 November 2026, supporting commercialization, international expansion and technology development.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Germany
Loading profile details…
Loading recent changes…